StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
645
This month
4
This week
3
This year
160
Yesterday
1
Publishing Date
2023 - 10 - 15
3
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 30
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 09
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 11 - 02
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
4
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
4
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 21
3
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 03 - 26
2
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2021 - 01 - 08
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
2
Sector
Commercial services
3
Communications
30
Consumer durables
2
Consumer non-durables
6
Consumer services
2
Distribution services
2
Electronic technology
6
Energy minerals
2
Finance
11
Finance and insurance
1
Health services
3
Health technology
645
Industrial services
2
Manufacturing
62
Miscellaneous
3
N/a
16
Process industries
5
Producer manufacturing
4
Professional, scientific, and technical services
12
Retail trade
2
Technology services
4
Utilities
1
Tags
Acquisition
8
Alliances
8
Antiviral
10
Application
20
Approval
30
Authorization
13
Cancer
58
Candidate
16
Children
16
Clinical-trials-phase-ii
9
Clinical-trials-phase-iii
13
Collaboration
20
Comirnaty®
10
Conference
16
Covid
58
Covid-19
41
Disease
26
Drug
49
Earnings
19
Ema
9
Emergency use authorization
10
Europe
11
Events
12
Expected
10
Fda
71
Fda-approvals
13
Financial
16
Global
53
Growth
29
Hiv
14
Hormone
10
License
18
Market
97
Merge
15
N/a
403
Order
15
People
23
Pharm-country
27
Pharmaceutical
17
Phase 2
12
Phase 3
21
Positive
42
Potential
11
Rare
9
Regulatory
12
Report
48
Research
49
Respiratory
10
Results
58
Risk
13
Study
18
Therapeutics
37
Therapy
28
Topline
14
Treatment
68
Trial
43
Ulcerative colitis
12
Update
13
Vaccine
106
Valneva
9
Entities
3m company
874
Abb ltd
1306
Abbott laboratories
1556
Abbvie inc.
918
Accenture plc
542
Alphabet inc.
1116
Amgen inc.
698
Apple inc.
1097
Arcelormittal
504
Arrival
3820
Astrazeneca plc
589
Athena consumer acquisition corp.
523
Becton, dickinson and company
724
Bnp paribas
1634
Boston scientific corporation
526
Bristol-myers squibb company
598
Broadcom inc.
523
Cisco systems, inc.
815
Danaher corporation
726
Dell technologies inc.
521
Dow inc.
522
Eli lilly and company
1555
Ericsson
1467
Extreme networks, inc.
581
First bank
558
Ford motor company
569
Gartner, inc.
530
General electric company
852
Glaxosmithkline plc
830
Honeywell international inc.
1621
Hubspot, inc.
1306
Intel corporation
882
International business machines corporation
606
Johnson & johnson
3999
Kering
1008
Koninklijke philips n.v.
887
Lithium corp
876
Live nation entertainment, inc.
718
Lockheed martin corporation
521
Medtronic plc
1197
Microsoft corporation
1128
Morgan stanley
3656
Nokia corp
887
Nokia corporation
825
Northrop grumman corporation
533
Novartis ag
1113
Novo nordisk a/s
568
Oracle corporation
1083
Orange
6134
Panasonic corp
592
Pfizer, inc.
645
Sanofi
4012
Sap se
1379
Snowflake inc.
709
Teva pharmaceutical industries ltd
567
Thermo fisher scientific inc
1434
Total se
1583
Verizon communications inc.
1065
Vision sensing acquisition corp.
504
X financial
568
Symbols
ABBV
36
ABT
31
ADCT
5
AGIO
10
ALNY
14
ALPMF
19
ALPMY
19
ALXN
17
AMGN
34
ARNA
10
ARVN
19
AVEO
10
AZN
43
AZNCF
33
BAX
6
BCRX
14
BDX
6
BEAM
6
BGNE
10
BHVN
15
BMY
60
BNTX
94
BPMC
10
CLVS
11
ENDP
6
EPZM
11
EXEL
13
FNCTF
29
GBT
6
GILD
26
GLAXF
41
GSK
64
ILMN
12
INCY
14
JNJ
76
KPTI
10
LLY
79
MRNA
7
MYL
14
MYOV
14
NEOS
13
NVO
10
NVS
81
NVSEF
61
OMER
13
OPK
6
OTIC
13
PFE
645
REGN
22
RIGL
11
SNY
152
SNYNF
89
TAK
23
TEVJF
28
TRIL
8
VSTM
10
VTRS
8
VYGR
6
XERS
10
YMAB
10
Exchanges
Amex
6
Lse
27
Nasdaq
411
Nyse
645
Tsx
2
Crawled Date
2023 - 10 - 16
5
2023 - 06 - 12
3
2023 - 05 - 25
3
2023 - 05 - 02
3
2023 - 04 - 04
3
2023 - 01 - 25
3
2022 - 12 - 22
3
2022 - 12 - 01
3
2022 - 11 - 08
3
2022 - 09 - 28
3
2022 - 08 - 25
3
2022 - 08 - 22
3
2022 - 08 - 18
3
2022 - 08 - 08
3
2022 - 07 - 28
3
2022 - 07 - 20
3
2022 - 06 - 27
3
2022 - 06 - 06
3
2022 - 05 - 24
3
2022 - 04 - 26
3
2022 - 03 - 29
3
2022 - 03 - 01
3
2022 - 01 - 05
3
2021 - 11 - 17
4
2021 - 11 - 09
5
2021 - 11 - 02
3
2021 - 10 - 21
3
2021 - 10 - 20
3
2021 - 09 - 28
6
2021 - 08 - 13
3
2021 - 08 - 12
3
2021 - 08 - 05
4
2021 - 07 - 23
3
2021 - 07 - 19
3
2021 - 06 - 24
4
2021 - 06 - 16
3
2021 - 06 - 09
3
2021 - 05 - 20
4
2021 - 05 - 04
3
2021 - 04 - 28
3
2021 - 04 - 22
3
2021 - 04 - 13
3
2021 - 04 - 08
2
2021 - 04 - 07
2
2021 - 04 - 01
2
2021 - 03 - 31
2
2021 - 03 - 26
2
2021 - 03 - 25
2
2021 - 03 - 23
2
2021 - 03 - 19
4
2021 - 03 - 18
3
2021 - 03 - 11
2
2021 - 03 - 10
2
2021 - 03 - 08
2
2021 - 02 - 17
3
2021 - 01 - 12
2
2020 - 12 - 28
2
2020 - 12 - 23
3
2020 - 12 - 21
2
2020 - 12 - 11
3
Crawled Time
00:00
22
00:01
1
00:20
4
01:00
13
02:00
5
03:00
1
04:00
4
04:20
1
05:00
9
05:03
1
05:10
1
06:00
8
06:03
2
07:00
10
08:00
3
08:20
3
09:00
11
09:01
1
10:00
15
10:51
1
11:00
64
11:01
1
12:00
81
12:03
1
12:15
4
12:20
16
12:30
9
12:34
1
13:00
44
13:01
1
13:07
1
13:14
1
13:15
3
13:17
1
13:20
6
13:27
1
13:30
4
13:50
1
13:55
1
14:00
34
14:03
1
14:15
2
14:20
5
14:30
1
15:00
33
15:15
3
15:20
9
15:21
1
15:28
1
15:30
3
16:00
36
16:20
2
17:00
22
18:00
21
18:31
2
19:00
20
20:00
16
21:00
23
22:00
25
23:00
13
Source
ir.akerotx.com
2
ir.vaccinex.com
1
ir.voyagertherapeutics.com
3
mindmed.co
1
www.4dpharmaplc.com
1
www.achievelifesciences.com
2
www.biospace.com
242
www.chi-med.com
1
www.eyenoviabio.com
1
www.fda.gov
31
www.globenewswire.com
135
www.prnewswire.com
225
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Pfizer, inc.
save search
Arvinas to Host Conference Call and Webcast to Discuss Vepdegestrant (ARV-471) Data Presented at 2023 San Antonio Breast Cancer Symposium and Plans to Expand Vepdegestrant Development Program
Published:
2023-12-06
(Crawled : 04:00)
- globenewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-0.21%
|
O:
-0.21%
H:
0.0%
C:
0.0%
ARVN
|
News
|
$32.71
7.95%
7.37%
1.6M
|
Health Technology
|
1.93%
|
O:
1.93%
H:
0.0%
C:
0.0%
arv-471
conference
breast
symposium
cancer
program
Arvinas and Pfizer Announce Interim Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®) and Plans to Expand Vepdegestrant Development Program
Published:
2023-12-05
(Crawled : 19:00)
- globenewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-0.21%
|
O:
-0.21%
H:
0.0%
C:
0.0%
ARVN
|
News
|
$32.71
7.95%
7.37%
1.6M
|
Health Technology
|
1.93%
|
O:
1.93%
H:
0.0%
C:
0.0%
ibrance
program
trial
Pfizer and Valneva Complete Recruitment for Phase 3 VALOR Trial for Lyme Disease Vaccine Candidate, VLA15
Published:
2023-12-04
(Crawled : 21:00)
- globenewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-0.46%
|
O:
-0.26%
H:
0.0%
C:
0.0%
vla15
disease
vaccine
valneva
trial
Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity
Published:
2023-12-01
(Crawled : 22:00)
- biospace.com/
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-3.87%
|
O:
-4.15%
H:
0.0%
C:
0.0%
obesity
topline
results
FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Cancer
Published:
2023-11-30
(Crawled : 22:00)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-3.87%
|
O:
-4.15%
H:
0.0%
C:
0.0%
padcev
fda
license
review
bladder
cancer
treatment
application
grants
Astellas' Fezolinetant Reduces Frequency and Severity of VMS Associated with Menopause in Women Considered Unsuitable for Hormone Therapy
Published:
2023-11-29
(Crawled : 00:00)
- prnewswire.com
ALPMY
|
$12.15
0.99%
590K
|
Manufacturing
|
0.17%
|
O:
0.66%
H:
0.0%
C:
-0.16%
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-2.22%
|
O:
1.71%
H:
0.0%
C:
0.0%
women
therapy
hormone
Arvinas and Pfizer Announce Updated Vepdegestrant (ARV-471) Data to be Presented at the 2023 San Antonio Breast Cancer Symposium
Published:
2023-11-28
(Crawled : 22:00)
- globenewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-3.34%
|
O:
-1.15%
H:
0.0%
C:
0.0%
ARVN
|
News
|
$32.71
7.95%
7.37%
1.6M
|
Health Technology
|
-0.33%
|
O:
1.72%
H:
4.07%
C:
0.6%
arv-471
breast
symposium
cancer
Arvinas Announces Oversubscribed $350 Million Private Placement
Published:
2023-11-27
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-4.31%
|
O:
0.81%
H:
0.0%
C:
0.0%
ARVN
|
News
|
$32.71
7.95%
7.37%
1.6M
|
Health Technology
|
11.6%
|
O:
2.8%
H:
11.93%
C:
7.54%
Global Synthetic Hormones Market Analysis and Forecast, 2023-2033: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape
Published:
2023-11-25
(Crawled : 00:20)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
5 d
|
$588.27
-0.17%
-0.1%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
0 d
|
$95.93
-1.15%
0.0%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
0 d
|
$96.87
4.13%
220
|
Health Technology
|
Email alert
Add to watchlist
global
market
Global Vaginitis Therapeutics Market Size Projected to Reach USD 7.20 Billion By 2032, With 8.1% CAGR Growth: Polaris Market Research
Published:
2023-11-23
(Crawled : 15:30)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
0 d
|
$96.87
4.13%
220
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
0 d
|
$95.93
-1.15%
0.0%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
reach
research
global
therapeutics
market
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference - November 21, 2023
Published:
2023-11-21
(Crawled : 17:00)
- biospace.com/
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-2.94%
|
O:
0.13%
H:
1.13%
C:
0.93%
conference
Pfizer and Astellas' XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
Published:
2023-11-17
(Crawled : 04:00)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-3.93%
|
O:
-1.09%
H:
0.0%
C:
0.0%
xtandi
fda
approved
cancer
treatment
Oncology Drugs Market worth $520 billion by 2033 - Exclusive Report by We Market Research
Published:
2023-11-10
(Crawled : 15:00)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-6.88%
|
O:
-4.83%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$155.4
-0.78%
-0.02%
6.4M
|
Health Technology
|
5.67%
|
O:
-1.24%
H:
0.0%
C:
0.0%
BMY
P
|
$50.16
0.56%
0.0%
14M
|
Health Technology
|
-5.13%
|
O:
-3.68%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
5.0%
|
O:
0.44%
H:
0.0%
C:
0.0%
AZN
|
News
|
$63.5
-0.14%
-0.14%
6.2M
|
Health Technology
|
-1.02%
|
O:
-2.88%
H:
0.0%
C:
0.0%
report
research
market
Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-11-07
(Crawled : 12:00)
- globenewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-7.18%
|
O:
-0.86%
H:
0.98%
C:
0.55%
ARVN
|
News
|
$32.71
7.95%
7.37%
1.6M
|
Health Technology
|
40.45%
|
O:
-1.33%
H:
4.2%
C:
4.04%
update
financial
results
Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference
Published:
2023-11-07
(Crawled : 06:00)
- globenewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-7.18%
|
O:
-0.86%
H:
0.98%
C:
0.55%
conference
valneva
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published:
2023-11-06
(Crawled : 12:00)
- globenewswire.com
GNMSF
|
$313.75
-0.02%
1.4K
|
Health Technology
|
15.2%
|
O:
4.19%
H:
3.29%
C:
-1.11%
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-5.73%
|
O:
1.55%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.06
0.17%
0.17%
1.9M
|
Health Technology
|
1.51%
|
O:
0.21%
H:
0.0%
C:
0.0%
GMAB
|
$32.35
0.56%
0.56%
450K
|
Health Technology
|
10.32%
|
O:
0.93%
H:
0.44%
C:
-1.37%
BNTX
|
$101.94
0.59%
0.59%
810K
|
Health Technology
|
3.62%
|
O:
6.29%
H:
3.18%
C:
-1.55%
update
financial
results
Pfizer Reports Third-Quarter 2023 Results
Published:
2023-10-31
(Crawled : 12:00)
- biospace.com/
HLN
|
$8.22
1.23%
0.37%
5.6M
|
n/a
|
2.18%
|
O:
0.87%
H:
0.0%
C:
0.0%
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-3.87%
|
O:
0.36%
H:
0.0%
C:
0.0%
BNTX
|
$101.94
0.59%
0.59%
810K
|
Health Technology
|
7.86%
|
O:
1.59%
H:
0.0%
C:
0.0%
AZN
|
News
|
$63.5
-0.14%
-0.14%
6.2M
|
Health Technology
|
2.63%
|
O:
0.14%
H:
0.0%
C:
0.0%
results
Anti-inflammatory Therapeutics Market Size to Hit US$ 149.5 billion by 2031 | Exclusive Study by Transparency Market Research
Published:
2023-10-30
(Crawled : 09:00)
- prnewswire.com
SNYNF
|
News
|
$92.11
3.42%
640
|
Health Technology
|
9.46%
|
O:
2.76%
H:
0.0%
C:
0.0%
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-6.19%
|
O:
-2.42%
H:
0.0%
C:
0.0%
NVS
|
News
0 d
|
$95.93
-1.15%
0.0%
1.2M
|
Health Technology
|
3.73%
|
O:
-0.15%
H:
0.25%
C:
-0.07%
JNJ
|
News
|
$155.4
-0.78%
-0.02%
6.4M
|
Health Technology
|
7.01%
|
O:
-1.39%
H:
0.79%
C:
0.64%
GSK
|
News
|
$36.0
-0.47%
0.06%
2.2M
|
Health Technology
|
2.83%
|
O:
0.03%
H:
0.44%
C:
-0.23%
ABBV
|
News
|
$147.97
1.09%
0.05%
7.2M
|
Health Technology
|
5.33%
|
O:
2.87%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.06
0.17%
0.17%
1.9M
|
Health Technology
|
3.33%
|
O:
-0.85%
H:
0.0%
C:
0.0%
research
therapeutics
study
market
Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
Published:
2023-10-27
(Crawled : 06:00)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-4.72%
|
O:
1.57%
H:
0.0%
C:
0.0%
nefecon
nephropathy
drug
approval
treatment
application
Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon® Chinese Patient Data and to Hold Conference Calls
Published:
2023-10-27
(Crawled : 01:00)
- prnewswire.com
PFE
|
News
A
|
$28.63
-0.56%
0.0%
35M
|
Health Technology
|
-4.72%
|
O:
1.57%
H:
0.0%
C:
0.0%
CALT
|
$17.8004
-0.56%
2.2K
|
Health Technology
|
9.02%
|
O:
2.58%
H:
0.08%
C:
-3.42%
nefecon
conference
kidney
presentation
chinese
week
← Previous
1
2
3
4
5
6
7
8
9
…
32
33
Next →
Gainers vs Losers
69%
31%
Top 10 Gainers
SLDB
M
|
$5.89
72.22%
41.94%
12M
|
Health Technology
SVFD
|
$3.09
43.72%
30.42%
64M
|
FTEL
|
$2.04
43.66%
30.39%
110K
|
HPCO
4
|
$0.4824
41.92%
29.54%
28M
|
ALGS
|
$0.6475
-5.06%
26.67%
2.1M
|
Health Technology
GTHX
|
$3.16
30.58%
23.42%
10M
|
Health Technology
KEQU
|
News
|
$22.5
27.62%
21.64%
24K
|
Producer Manufacturing
GSIT
|
$3.09
27.16%
21.36%
2.2M
|
Electronic Technology
SSKN
P
|
$0.628
25.6%
20.38%
210K
|
Health Technology
GLUE
|
$3.66
22.82%
18.58%
510K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.